Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy

Aeberli, Daniel; Schett, Georg (2013). Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy. Arthritis research & therapy, 15(2), p. 208. BioMed Central 10.1186/ar4180

[img]
Preview
Text
ar4180.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (569kB) | Preview

Bone mass, bone geometry and its changes are based on trabecular and cortical bone remodeling. Whereas the effects of estrogen loss, rheumatoid arthritis (RA), glucocorticoid (GC) and bisphosphonate (BP) on trabecular bone remodeling have been well described, the effects of these conditions on the cortical bone geometry are less known. The present review will report current knowledge on the effects of RA, GC and BP on cortical bone geometry and its clinical relevance. Estrogen deficiency, RA and systemic GC lead to enhanced endosteal bone resorption. While in estrogen deficiency and under GC therapy endosteal resorption is insufficiently compensated by periosteal apposition, RA is associated with some periosteal bone apposition resulting in a maintained load-bearing capacity and stiffness. In contrast, BP treatment leads to filling of endosteal bone cavities at the epiphysis; however, periosteal apposition at the bone shaft seems to be suppressed. In summary, estrogen loss, RA and GC show similar effects on endosteal bone remodeling with an increase in bone resorption, whereas their effect on periosteal bone remodeling may differ. Despite over 50 years of GC therapy and over 25 years of PB therapy, there is still need for better understanding of the skeletal effects of these drugs as well as of inflammatory disease such as RA on cortical bone remodeling.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Aeberli, Daniel

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1478-6354

Publisher:

BioMed Central

Language:

English

Submitter:

Stefan Kuchen

Date Deposited:

02 Apr 2014 11:44

Last Modified:

07 Dec 2014 10:11

Publisher DOI:

10.1186/ar4180

PubMed ID:

23521873

BORIS DOI:

10.7892/boris.42987

URI:

https://boris.unibe.ch/id/eprint/42987

Actions (login required)

Edit item Edit item
Provide Feedback